Quick Answer
Edgewise Therapeutics, Inc. reported Shares Outstanding of 106.25 million shares for fiscal year 2025.
Edgewise Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 106.25M | +12.0% |
| 2024 | 94.84M | +34.6% |
| 2023 | 70.45M | +11.4% |
| 2022 | 63.26M | +27.8% |
| 2021 | 49.50M | +4803.6% |
| 2020 | 1.01M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 105.76M | +12.0% | +0.4% |
| June 30, 2025 | 105.34M | +12.5% | +10.6% |
| March 31, 2025 | 95.21M | +2.1% | +0.4% |
| December 31, 2024 | 94.84M | +34.6% | +0.5% |
| September 30, 2024 | 94.41M | +48.8% | +0.8% |
| June 30, 2024 | 93.64M | +47.6% | +0.4% |
| March 31, 2024 | 93.28M | +47.4% | +32.4% |
| December 31, 2023 | 70.45M | +11.4% | +11.0% |
- Edgewise Therapeutics, Inc. showed an increase of +12.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Edgewise Therapeutics, Inc.’s shares outstanding has grown by 10425.2% (from 1.01 million shares to 106.25 million shares).
- The most recent figure is from Edgewise Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: